Search
14 hours ago
Daejeon based Orum Therapeutics is pioneering the field of degrader-antibody conjugates. Founder SJ Lee describes the science and gives us an overview of biotech in Korea
He explains the power of protein degradation, and the upside to Orum's targeted delivery approach. Plus, selling an asset to Bristol...